116 related articles for article (PubMed ID: 34517565)
1. Upregulation of BIRC5 plays essential role in esophageal squamous cell carcinoma.
Chen ZX; Li GS; Yang LH; Liu HC; Qin GM; Shen L; He WY; Gan TQ; Li JJ
Math Biosci Eng; 2021 Aug; 18(5):6941-6960. PubMed ID: 34517565
[TBL] [Abstract][Full Text] [Related]
2. NRF2/HO-1 axis, BIRC5, and TP53 expression in ESCC and its correlation with clinical pathological characteristics and prognosis.
Gao Y; Wan L; Li M; Wang B; Ma Y
Int J Biol Markers; 2023 Dec; 38(3-4):174-184. PubMed ID: 37312528
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis.
Li R; Pang XF; Huang ZG; Yang LH; Peng ZG; Ma J; He RQ
BMC Cancer; 2021 Sep; 21(1):996. PubMed ID: 34488675
[TBL] [Abstract][Full Text] [Related]
4. The effect of polymorphisms in the promoter of the BIRC5 gene on the risk of oesophageal squamous cell carcinoma and patient's outcomes.
Wang N; Li Y; Zhou RM; Cui SJ; Cao SR; Huang X; Huo XR; Shan BE
Mutagenesis; 2019 Dec; 34(4):307-313. PubMed ID: 31165868
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
Liu Z; Yang T; Xu Z; Cao X
Biomed Pharmacother; 2016 Aug; 82():406-12. PubMed ID: 27470379
[TBL] [Abstract][Full Text] [Related]
6. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis.
Chen FJ; Sun M; Li SQ; Wu QQ; Ji L; Liu ZL; Zhou GZ; Cao G; Jin L; Xie HW; Wang CM; Lv J; De W; Wu M; Cao XF
Mol Carcinog; 2013 Nov; 52(11):908-15. PubMed ID: 24151120
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of cyclin-dependent kinase 1 in esophageal squamous cell carcinoma and its clinical significance.
Zhang HJ; Chen G; Chen SW; Fu ZW; Zhou HF; Feng ZB; Mo JX; Li CB; Liu J
FEBS Open Bio; 2021 Nov; 11(11):3126-3141. PubMed ID: 34586751
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of the long noncoding RNA PCAT-1 correlates with advanced clinical stage and poor prognosis in esophageal squamous carcinoma.
Shi WH; Wu QQ; Li SQ; Yang TX; Liu ZH; Tong YS; Tuo L; Wang S; Cao XF
Tumour Biol; 2015 Apr; 36(4):2501-7. PubMed ID: 25731728
[TBL] [Abstract][Full Text] [Related]
10. Upregulated ataxia-telangiectasia group D complementing gene correlates with poor prognosis in patients with esophageal squamous cell carcinoma.
Lai W; Zhao J; Zhang C; Cui D; Lin J; He Y; Zheng H; Wu X; Yang M
Dis Esophagus; 2013; 26(8):817-22. PubMed ID: 23020249
[TBL] [Abstract][Full Text] [Related]
11. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
12. Expression of Rac-1 related to tumor depth, lymph node metastasis and patient prognosis in esophageal squamous cell carcinoma.
Yang Q; Luo GY; Li Y; Shan HB; Wang HY; Xu GL
Med Oncol; 2013 Dec; 30(4):689. PubMed ID: 24026656
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of the RNA-binding motif protein 43 predicts poor prognosis in esophageal squamous cell carcinoma.
Li Y; Liu LL; Hu R; Sun Q; Wen XB; Luo RZ; Yan SM
Int J Clin Oncol; 2021 Oct; 26(10):1847-1855. PubMed ID: 34398362
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of matrix metalloproteinase 10 is associated with poor survival in patients with early stage of esophageal squamous cell carcinoma.
Liu H; Qin YR; Bi J; Guo A; Fu L; Guan XY
Dis Esophagus; 2012; 25(7):656-63. PubMed ID: 22121946
[TBL] [Abstract][Full Text] [Related]
15. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.
Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF
Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043
[TBL] [Abstract][Full Text] [Related]
16. A novel long non-coding RNA FOXCUT and mRNA FOXC1 pair promote progression and predict poor prognosis in esophageal squamous cell carcinoma.
Pan F; Yao J; Chen Y; Zhou C; Geng P; Mao H; Fang X
Int J Clin Exp Pathol; 2014; 7(6):2838-49. PubMed ID: 25031703
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value and functional bioinformatic analysis of spindle- and kinetochore-associated protein 1 in stage IIA esophageal squamous cell carcinoma.
Hu D; Zhang M; Peng Z
J Cancer Res Ther; 2020 Sep; 16(5):1157-1164. PubMed ID: 33004764
[TBL] [Abstract][Full Text] [Related]
18. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
[TBL] [Abstract][Full Text] [Related]
19. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ
J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985
[TBL] [Abstract][Full Text] [Related]
20. The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma.
Zhang W; Zhou Y; Li C; Xu S; Li M; Liu W; Ma Y; Wang H
Anal Cell Pathol (Amst); 2020; 2020():2872479. PubMed ID: 33381388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
